230 related articles for article (PubMed ID: 17564582)
1. The EWS-Oct-4 fusion gene encodes a transforming gene.
Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
[TBL] [Abstract][Full Text] [Related]
2. EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours.
Kim S; Lim B; Kim J
Br J Cancer; 2010 Jan; 102(2):436-46. PubMed ID: 20051954
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
4. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
Lee SB; Kolquist KA; Nichols K; Englert C; Maheswaran S; Ladanyi M; Gerald WL; Haber DA
Nat Genet; 1997 Nov; 17(3):309-13. PubMed ID: 9354795
[TBL] [Abstract][Full Text] [Related]
5. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
6. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator.
Labelle Y; Bussières J; Courjal F; Goldring MB
Oncogene; 1999 May; 18(21):3303-8. PubMed ID: 10359536
[TBL] [Abstract][Full Text] [Related]
7. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties.
Kim J; Lee K; Pelletier J
Oncogene; 1998 Apr; 16(15):1973-9. PubMed ID: 9591781
[TBL] [Abstract][Full Text] [Related]
8. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct.
Kim J; Lee K; Pelletier J
Oncogene; 1998 Feb; 16(8):1021-30. PubMed ID: 9519876
[TBL] [Abstract][Full Text] [Related]
9. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.
Fujimura Y; Ohno T; Siddique H; Lee L; Rao VN; Reddy ES
Oncogene; 1996 Jan; 12(1):159-67. PubMed ID: 8552387
[TBL] [Abstract][Full Text] [Related]
10. Critical role of the fibroblast growth factor signalling pathway in Ewing's sarcoma octamer-binding transcription factor 4-mediated cell proliferation and tumorigenesis.
Kim J; Kim HS; Shim JJ; Lee J; Kim AY; Kim J
FEBS J; 2019 Nov; 286(22):4443-4472. PubMed ID: 31155838
[TBL] [Abstract][Full Text] [Related]
11. Mutation in the DNA-binding domain of the EWS-Oct-4 oncogene results in dominant negative activity that interferes with EWS-Oct-4-mediated transactivation.
Kim S; Lee J; Kim JY; Lim B; Shin EK; Han YM; Kim SS; Song JH; Kim J
Int J Cancer; 2009 May; 124(10):2312-22. PubMed ID: 19170206
[TBL] [Abstract][Full Text] [Related]
12. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
Bertolotti A; Bell B; Tora L
Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
[TBL] [Abstract][Full Text] [Related]
14. A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Werner H; Idelman G; Rubinstein M; Pattee P; Nagalla SR; Roberts CT
Cancer Lett; 2007 Mar; 247(1):84-90. PubMed ID: 16730884
[TBL] [Abstract][Full Text] [Related]
15. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
Petermann R; Mossier BM; Aryee DN; Khazak V; Golemis EA; Kovar H
Oncogene; 1998 Aug; 17(5):603-10. PubMed ID: 9704926
[TBL] [Abstract][Full Text] [Related]
17. A novel zinc finger gene is fused to EWS in small round cell tumor.
Mastrangelo T; Modena P; Tornielli S; Bullrich F; Testi MA; Mezzelani A; Radice P; Azzarelli A; Pilotti S; Croce CM; Pierotti MA; Sozzi G
Oncogene; 2000 Aug; 19(33):3799-804. PubMed ID: 10949935
[TBL] [Abstract][Full Text] [Related]
18. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
Coles EG; Lawlor ER; Bronner-Fraser M
Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.
Speleman F; Delattre O; Peter M; Hauben E; Van Roy N; Van Marck E
Mod Pathol; 1997 May; 10(5):496-9. PubMed ID: 9160316
[TBL] [Abstract][Full Text] [Related]
20. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12).
Yamaguchi S; Yamazaki Y; Ishikawa Y; Kawaguchi N; Mukai H; Nakamura T
Genes Chromosomes Cancer; 2005 Jun; 43(2):217-22. PubMed ID: 15729702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
